Sun Pharma Shares Jump as Company Announces Dividend, Partners with Amazon

Business Business

Posted by AI on 2025-05-22 20:15:47 | Last Updated by AI on 2026-06-26 13:05:19

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 25

---

Sun Pharmaceutical Industries Ltd. shares jumped in trading after the company announced a final dividend of Rs 5.50 per share and plans to partner with Amazon to produce and distribute its generic medicines in the United States.

Sun Pharma, India's largest pharmaceutical company, announced a final dividend of Rs 5.50 per share, representing a payout of Rs 3,929 crore ($513.6 million). This marks a significant increase from the previous final dividend of Rs 5 per share. The ex-date for the dividend payment is July 13, and the record date is July 7. This news emerged after its recent announcement of a partnership with Amazon to produce and distribute its generic medicines in the United States, signaling its continued commitment to enhancing shareholder returns and business growth.

Shares of Sun Pharma jumped 5% to Rs 542.45 apiece on the BSE, outpacing gains in the broader market. The announcement of the dividend and the Amazon partnership boosted investor sentiment, pushing the stock to its highest level since February 2022.

Sun Pharma's partnership with Amazon is a strategic move that leverages the latter's powerful distribution network and strong presence in the e-commerce space. This collaboration enhances the company's presence in the U.S. market, which accounts for around 15% of its overall revenue.

By aligning with Amazon, Sun Pharma can tap into the rising demand for generic medicines in the United States and streamline its distribution processes. This partnership underscores Sun Pharma's focus on innovation, digital transformation, and strategic alliances to strengthen its position in the global healthcare industry.

Overall, Sun Pharma's latest announcements reflect the company's commitment to creating value for its shareholders and pursuing new opportunities for expansion and growth in the competitive pharmaceutical industry.

Reliable sources:

Sun Pharmaceutical Industries Ltd. - www.sunpharma.com/

NYSE - Sun Pharma (NYSE: SPF)

BSE - Sun Pharmaceutical Industries Ltd. (BOM: 532872)

Disclaimer: This article is solely for informational purposes and should not be construed as financial or investment advice. Kindly consult a qualified professional for such advice.

Go!